ITMI20080187A1 - Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo - Google Patents
Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamoloInfo
- Publication number
- ITMI20080187A1 ITMI20080187A1 IT000187A ITMI20080187A ITMI20080187A1 IT MI20080187 A1 ITMI20080187 A1 IT MI20080187A1 IT 000187 A IT000187 A IT 000187A IT MI20080187 A ITMI20080187 A IT MI20080187A IT MI20080187 A1 ITMI20080187 A1 IT MI20080187A1
- Authority
- IT
- Italy
- Prior art keywords
- paracetamol
- hepatic
- prevention
- damage
- amino acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000187A ITMI20080187A1 (it) | 2008-02-07 | 2008-02-07 | Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo |
PCT/EP2008/008261 WO2009097874A1 (en) | 2008-02-07 | 2008-09-29 | Amino acid formulations comprising cysteine, methionine and/or serine for the prevention of paracetamol-induced liver damage |
EP08802695.0A EP2252279B1 (en) | 2008-02-07 | 2008-09-29 | Amino acid formulations comprising cysteine, methionine and serine for the prevention of paracetamol-induced liver damage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000187A ITMI20080187A1 (it) | 2008-02-07 | 2008-02-07 | Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo |
Publications (1)
Publication Number | Publication Date |
---|---|
ITMI20080187A1 true ITMI20080187A1 (it) | 2009-08-08 |
Family
ID=40159372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT000187A ITMI20080187A1 (it) | 2008-02-07 | 2008-02-07 | Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2252279B1 (it) |
IT (1) | ITMI20080187A1 (it) |
WO (1) | WO2009097874A1 (it) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013175479A1 (en) | 2012-05-24 | 2013-11-28 | Hadasit Medical Research Services And Development Ltd. | Compositions comprising isosilybin b for amelioration and prevention of drug- induced toxicity |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474757A (en) * | 1992-10-16 | 1995-12-12 | Rutgers University | Prevention of acetaminophen overdose toxicity with organosulfur compounds |
GB9305058D0 (en) * | 1993-03-12 | 1993-04-28 | Penn Pharm Ltd | Pharmaceutical compositions |
FR2744917B1 (fr) * | 1996-02-16 | 1998-04-10 | Kouchner Gerard | Composition therapeutique a base d'acetaminophene |
AU5882298A (en) * | 1997-01-29 | 1998-08-18 | Chong Kun Dang Corporation | New analgesic composition |
WO2001068069A2 (en) * | 2000-03-15 | 2001-09-20 | King's College London | Pharmaceutical composition comprising paracetamol |
US20050220862A1 (en) * | 2004-03-31 | 2005-10-06 | Bernstein Joel E | Compositions with reduced hepatotoxicity |
US20070098790A1 (en) * | 2005-10-31 | 2007-05-03 | David Jiang | Nutritional supplement for the enhancement of the health of the liver |
US20080139654A1 (en) * | 2006-12-09 | 2008-06-12 | Eric Mott Soderling | Acetaminophen compositions having minimized side effects including reduced hepatotoxicity |
-
2008
- 2008-02-07 IT IT000187A patent/ITMI20080187A1/it unknown
- 2008-09-29 EP EP08802695.0A patent/EP2252279B1/en not_active Not-in-force
- 2008-09-29 WO PCT/EP2008/008261 patent/WO2009097874A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2252279B1 (en) | 2013-09-11 |
EP2252279A1 (en) | 2010-11-24 |
WO2009097874A1 (en) | 2009-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018030I2 (el) | Φαρμακοτεχνικη μορφη 514 | |
SMT201700095B (is) | Composizioni farmaceutiche per inalazione | |
DK3061445T3 (da) | Højkoncentrerede farmaceutiske formuleringer | |
DK2254908T3 (da) | Kosmetiske eller farmaceutiske sammensætninger omfattende metalloproteinasehæmmere | |
BRPI0920082A2 (pt) | forma de dosagem oral de acetaminofeno/tramadol com liberação estendida. | |
DK2328601T3 (da) | Linaclotid-holdige formuleringer til oral indgivelse | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
HK1152478A1 (en) | Solid pharmaceutical formulations comprising bibw 2992 | |
DK2459221T3 (da) | Farmaceutisk formulering | |
GT201200303A (es) | Formulaciones farmacéuticas | |
BRPI1011650A2 (pt) | composições sólidas compreendendo ácido 5-aminolevulínico | |
BR112012004525A2 (pt) | composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno | |
BRPI0921654A2 (pt) | formulação farmacêutica | |
SMT201400053B (it) | Forme farmaceutiche orali di bendamustina | |
BRPI1007237A2 (pt) | composição farmacêutica compreendendo aleglitazar | |
ITMI20071261A1 (it) | Procedimento per la preparazione di cinacalcet | |
BRPI0912656A2 (pt) | formulação farmacêutica sólida | |
BRPI1013037A2 (pt) | "solução farmacêutica oral de telmisartan" | |
DK2271321T3 (da) | Farmaceutisk sammensætning 271 | |
BRPI0810790A2 (pt) | Formulações de aminoácidos n-halogenados | |
BRPI0914139A2 (pt) | composições pediátricas para o tratamento de esclerose múltipla | |
BRPI0913709A2 (pt) | "formulação farmacêutica" | |
ITMI20080187A1 (it) | Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo | |
IT1396373B1 (it) | Procedimento per la preparazione di fesoterodina. | |
BRPI0811073A2 (pt) | Formulações de amino ácido -n-halogenado contendo ácido alifático |